An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
Clinical trial NCT05367960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05367960
- Sponsor
- Tetra Discovery Partners
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2027-09-30
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.